Harish Shantharam
No más puestos en curso
Historial de carrera de Harish Shantharam
Antiguos cargos conocidos de Harish Shantharam.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 24/01/2024 | 22/03/2024 |
| Director Financiero/CFO | 22/05/2023 | 22/03/2024 | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2011 | 01/05/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2004 | 01/11/2011 |
Formación de Harish Shantharam.
| UCLA Anderson School of Management | Masters Business Admin |
| The University of Texas at Arlington | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Harish Shantharam
- Experiencia
